David H. Brown Ripin

2.4k total citations · 1 hit paper
39 papers, 1.7k citations indexed

About

David H. Brown Ripin is a scholar working on Organic Chemistry, Infectious Diseases and Molecular Biology. According to data from OpenAlex, David H. Brown Ripin has authored 39 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 14 papers in Infectious Diseases and 9 papers in Molecular Biology. Recurrent topics in David H. Brown Ripin's work include HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (10 papers) and HIV Research and Treatment (9 papers). David H. Brown Ripin is often cited by papers focused on HIV/AIDS drug development and treatment (13 papers), HIV/AIDS Research and Interventions (10 papers) and HIV Research and Treatment (9 papers). David H. Brown Ripin collaborates with scholars based in United States, United Kingdom and South Africa. David H. Brown Ripin's co-authors include John A. Ragan, Robert W. Dugger, Sally Gut Ruggeri, Stéphane Caron, David A. Evans, Timothy Norris, Michael G. Vetelino, Jeffrey S. Johnson, Charles Flexner and Kevin R. Campos and has published in prestigious journals such as Chemical Reviews, Journal of the American Chemical Society and Nature Communications.

In The Last Decade

David H. Brown Ripin

37 papers receiving 1.7k citations

Hit Papers

Large-Scale Oxidations in... 2006 2026 2012 2019 2006 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Large-Scale Oxidations in the Pharmaceutical Industry
    2006 716 citations Stéphane Caron, Robert W. Dugger et al. Chemical Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Brown Ripin United States 16 1.2k 304 281 252 218 39 1.7k
Pedro P. Corbi Brazil 24 1.0k 0.8× 291 1.0× 325 1.2× 361 1.4× 83 0.4× 131 1.9k
Yoshikazu Kimura Japan 21 849 0.7× 131 0.4× 253 0.9× 108 0.4× 102 0.5× 100 1.2k
Octávio Augusto Ceva Antunes Brazil 24 574 0.5× 422 1.4× 563 2.0× 508 2.0× 49 0.2× 96 1.7k
Saeed Ahmad Pakistan 25 1.5k 1.2× 673 2.2× 300 1.1× 327 1.3× 28 0.1× 152 2.4k
Joseph Fortunak United States 24 836 0.7× 203 0.7× 326 1.2× 42 0.2× 113 0.5× 55 1.5k
Pat Forgione Canada 20 1.3k 1.0× 146 0.5× 170 0.6× 117 0.5× 39 0.2× 68 1.6k
Thomas Tarnowski United States 17 412 0.3× 111 0.4× 294 1.0× 200 0.8× 113 0.5× 37 1.3k
Pedro de March Spain 26 1.7k 1.3× 136 0.4× 396 1.4× 97 0.4× 105 0.5× 110 2.0k
Maria Assunta Chiacchio Italy 22 875 0.7× 57 0.2× 401 1.4× 179 0.7× 83 0.4× 87 1.4k
Bin Hu United States 24 1.1k 0.9× 453 1.5× 554 2.0× 224 0.9× 93 0.4× 81 1.9k

Countries citing papers authored by David H. Brown Ripin

Since Specialization
Citations

This map shows the geographic impact of David H. Brown Ripin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Brown Ripin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Brown Ripin more than expected).

Fields of papers citing papers by David H. Brown Ripin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Brown Ripin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Brown Ripin. The network helps show where David H. Brown Ripin may publish in the future.

Co-authorship network of co-authors of David H. Brown Ripin

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Brown Ripin. A scholar is included among the top collaborators of David H. Brown Ripin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Brown Ripin. David H. Brown Ripin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phillips, Andrew, Jennifer S. Smith, Loveleen Bansi‐Matharu, et al.. (2025). Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in Africa. Nature Communications. 16(1). 5760–5760.
2.
Ripin, David H. Brown, et al.. (2023). Securing accelerated access to long‐acting injectable cabotegravir for HIV prevention in low‐ and middle‐income countries. Journal of the International AIDS Society. 26(S2). e26101–e26101. 7 indexed citations
3.
Lewin, Sharon R., Brian Doehle, Karine Dubé, et al.. (2020). Multi-stakeholder consensus on a target product profile for an HIV cure. The Lancet HIV. 8(1). e42–e50. 48 indexed citations
4.
5.
Vitória, Marco, Andrew Hill, Nathan Ford, et al.. (2018). The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries. AIDS. 32(12). 1551–1561. 76 indexed citations
6.
Ripin, David H. Brown, et al.. (2017). A cost-savings analysis of a candidate universal antiretroviral regimen. Current Opinion in HIV and AIDS. 12(4). 403–407. 3 indexed citations
7.
Ford, Nathan, Charles Flexner, Stefano Vella, David H. Brown Ripin, & Marco Vitória. (2013). Optimization and simplification of antiretroviral therapy for adults and children. Current Opinion in HIV and AIDS. 8(6). 591–599. 10 indexed citations
8.
Moore, Meredith, et al.. (2013). An overview of the antiretroviral market. Current Opinion in HIV and AIDS. 8(6). 535–543. 9 indexed citations
9.
Flexner, Charles, et al.. (2013). Treatment optimization. Current Opinion in HIV and AIDS. 8(6). 523–527. 6 indexed citations
10.
Crawford, Keith W., et al.. (2012). Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: a consensus statement. The Lancet Infectious Diseases. 12(7). 550–560. 31 indexed citations
11.
Essajee, Shaffiq, et al.. (2011). Optimizing Antiretroviral Product Selection: A Sample Approach to Improving Patient Outcomes, Saving Money, and Scaling-up Health Services in Developing Countries. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(Supplement 2). S100–S103. 2 indexed citations
12.
Ripin, David H. Brown, et al.. (2010). Synthesis of Tenofovir Disoproxil Fumarate. Synfacts. 2010(12). 1340–1340. 1 indexed citations
13.
Caron, Stéphane, Robert W. Dugger, Sally Gut Ruggeri, John A. Ragan, & David H. Brown Ripin. (2006). Large-Scale Oxidations in the Pharmaceutical Industry. Chemical Reviews. 106(7). 2943–2989. 716 indexed citations breakdown →
14.
Norris, Timothy, et al.. (2005). New hydroxy-pyrazoline intermediates, subtle regio-selectivity and relative reaction rate variations observed during acid catalyzed and neutral pyrazole cyclization. Organic & Biomolecular Chemistry. 3(10). 1844–1844. 77 indexed citations
15.
Ripin, David H. Brown, Thomas A. Brandt, Heather N. Frost, et al.. (2005). Evaluation of Kilogram-Scale Sonagashira, Suzuki, and Heck Coupling Routes to Oncology Candidate CP-724,714. Organic Process Research & Development. 9(4). 440–450. 52 indexed citations
16.
Ende, David J. am, et al.. (2004). Thermal stability investigation of pyridine substituted tosyl oximes. Thermochimica Acta. 419(1-2). 83–88. 6 indexed citations
17.
Bemish, Raymond J., et al.. (2001). Oxidation of carbamate-protected alkylhydrazines to the corresponding hydrazones under Swern conditions. Tetrahedron Letters. 42(8). 1453–1454. 2 indexed citations
18.
Ripin, David H. Brown, Weiling Cai, & Steven J. Brenek. (2000). A safe, scaleable method for the oxidation of carbon–boron bonds with oxone®. Tetrahedron Letters. 41(31). 5817–5819. 25 indexed citations
19.
Ripin, David H. Brown, Weiling Cai, & Steven J. Brenek. (2000). ChemInform Abstract: A Safe, Scalable Method for the Oxidation of Carbon—Boron Bonds with Oxone®.. ChemInform. 31(41). 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pedro P. Corbi Breakdown of academic impact, for papers by Yoshikazu Kimura Breakdown of academic impact, for papers by Octávio Augusto Ceva Antunes Breakdown of academic impact, for papers by Saeed Ahmad Breakdown of academic impact, for papers by Joseph Fortunak Breakdown of academic impact, for papers by Pat Forgione Breakdown of academic impact, for papers by Thomas Tarnowski Breakdown of academic impact, for papers by Pedro de March Breakdown of academic impact, for papers by Maria Assunta Chiacchio Breakdown of academic impact, for papers by Bin Hu
Rankless by CCL
2026